Some Quality Measures reporting has changed for 2018 reporting in Year 2 MIPS

Date: March 13, 2018

Recently, we became aware of a few differences in the Quality reporting codes for Year 2 MIPS (2018).  Some of these changes affect Quality Measures reporting codes that were commonly used in 2017.  Under Year 2 MIPS, Quality is reported for a full year, so it is vitally important for those reporting via claims to be aware of the changes.  Registry reports are affected as well, but since reporting for registries does not take place until early 2019, the urgency is not the same.  All 2018 Resources, including the Quality measure specifications sheets, can be accessed at this link.  The Measures that changed and affect eye providers are as follows.

 Measure 14:  Age-Related Macular Degeneration (AMD): Dilated Macular Exam

  • A common code for 2017 (2019F) is no longer active
  • For 2018 there are new codes:
    • Use G9974 when performance is met
      • There is no longer the option to use 1P, 2P, or 8P modifiers with this code
    • Use G9975, G9892, G9893 when performance is not met
    • “Unspecified Eye” diagnosis codes are no longer applicable

Measure 130Documentation of Current Medications in the Medical Record

  • CPT code 99024 (post-operative visit) is now included for the 2018 reporting year
  • Note: This only affects providers in groups of 10 or more providers in the following states, who should already be reporting 99024 on post-operative visits via claims:
    • FL, KY, LA, NV, NJ, ND, OH, OR, and RI

Measure 226Preventive Care and Screening:  Tobacco Use:  Screening and Cessation Intervention

  • The new specifications sheet notes there are now 3 submission criteria (a change from 2017):
    1. % patients age 18+ screened for tobacco use 1/more times within 24 months
    2. % patients age 18+ screened for tobacco use AND identified as a tobacco user who received tobacco cessation intervention
    3. % patients age 18+ screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
  • Providers must report on ALL applicable criteria (1, 2 and 3)

IMPORTANT:  Because of the above changes, Measure 226 appears to be VERY difficult to report successfully and make a high score.  Practices may want to consider NOT DOING this measure in 2018.

We are happy to assist providers and groups in any way.  Please contact us via one of the below or on our “App”, Corcoran 24/7, which can be accessed via one of the links below.

Recent News

CMS Extends Deadline for MIPS 2023 Data Submission

CMS has extended the data submission period for the Merit-based Incentive Payment System (MIPS) eligible clinicians who participated in the 2023 performance year of the ...

Congress Passed bill for MPFS

The recent passing of a partial government funding bill by Congress on March 8 is important to Medicare beneficiaries. This bill includes policies aimed at addressing ...

Change to Processing for Telehealth Services Billed with POS 10

In calendar year (CY) 2024, the Centers for Medicare & Medicaid Services (CMS) issued a change to processing for telehealth services billed with POS 10. ...

Diabetes Cost Measure Misattributed to Ophthalmologists

The American Society of Cataract and Refractive Surgery (ASCRS), the American Society of Retina Specialists (ASRS) and the American Academy of Ophthalmology (AAO), met recently ...

Review Your 2022 MIPS Performance Feedback and Final Scores

The Centers for Medicare & Medicaid Services (CMS) has released the Merit-Based Incentive Payment System (MIPS) performance feedback and final scores for the 2022 performance ...

JZ Modifier Required July 1, 2023

The much-anticipated mandatory reporting of the JZ modifier for Part B Medicare begins July 1, 2023.  The new Medicare policy can be found here.  The ...

Cigna Hits the Brakes on Their New Modifier 25 Policy

Following fierce opposition from the physician community, the insurer Cigna announced today a delay in implementing a policy (PDF) that would have required submitting medical ...

Medical Consulting Group and Corcoran Consulting Group Announce Merger

Springfield, MO, April 27th, 2023. Medical Consulting Group (MCG), a provider of consulting services to ophthalmic practices and companies, and Corcoran Consulting Group (CCG), a ...

IHEEZO Gel gains Medicare Pass-Through

On March 13, 2023, Harrow® announced that the Centers for Medicare & Medicaid Services (CMS) has approved transitional pass-through reimbursement status for chloroprocaine hydrochloride ophthalmic ...

Cigna Change Modifier 25 Policy

As a result of a recent review, Cigna has announced it will require the submission of office notes with claims submitted for evaluation and management ...

Congress makes positive adjustments that affect ophthalmologists

In this Healio Video Perspective from Hawaiian Eye 2023, Kevin J. Corcoran, COE, CPC, CPMA, FNAO, discusses ophthalmic economic and regulatory updates for the year. ...

HHS Extends Covid-19 PHE

On Thursday, October 13, the U.S. Department of Health & Human Services (HHS) Secretary Xavier Becerra extended the nation's COVID-19 PHE for an additional 90 ...

Noridian Changes to Goniotomy LCD

Noridian has made changes to their Goniotomy coverage policy effective October 1st, 2022. It states: “Since there is no specific CPT® code for goniopuncture or ...

2021 MIPS Performance Feedback, 2021 MIPS Final Score, and 2023 MIPS Payment Adjustment Information

The Centers for Medicare & Medicare Services (CMS) has released Merit-based Incentive Payment System (MIPS) performance feedback and final scores for the 2021 performance year, ...

Telehealth Place of Service Update

With a recent change to telehealth billing, billers need to be aware of an additional Place of Service code. What changed? Effective January 1, 2022, ...

Extension of Telehealth Flexibility

Last week, the U.S. House of Representatives approved legislation to further extend the Medicare telehealth flexibilities first instituted in response to the COVID-19 pandemic. If ...

AETNA No Longer Requiring Prior Authorization for Cataract Surgery

The American Society of Cataract and Refractive Surgery (ASCRS) and American Academy of Ophthalmology (AAO) have spearheaded a year-long effort to remove the policy that ...

2021 MIPS Final Score Preview Now Available

The Centers for Medicare & Medicaid Services (CMS) has opened the Final Score Preview period for the Merit-based Incentive Payment System (MIPS).  You can now ...

Guidance for Coding Goniotomy

Summary:   Two new ophthalmic surgical products have attracted interest from surgeons:  Streamline Viscoelastic Injector® (New World Medical) and IACCESS™ trabecular trephine (Glaukos).  In both cases, ...

CIGNA Changes Their Modifier 25 Policy

As a result of a recent review, CIGNA will require the submission of office notes with all claims submitted with evaluation and management (E/M) CPT ...

CMS Reweights Scoring for Cost Category for Groups in 2021 Quality Payment Program

The Centers for Medicare & Medicaid Services (CMS) announced on Monday, April 25th, that ALL eligible MIPS providers will automatically receive re-weighting of the Cost ...

IACCESS™ Trabecular Trephine – How to Code?

Summary:   Glaukos’ new product, the IACCESS™ trabecular trephine, raises interesting coding questions.  Standalone procedures should be reported on a claim for reimbursement as unlisted procedure, ...

Streamline® Viscoelastic Injector – How to Code?

Summary:   New World Medical’s new product, the Streamline® Viscoelastic Injector, raises interesting coding questions.  Standalone procedures with it should be reported on a claim for ...

HHS Extends the Public Health Emergency Waivers

On April 12, 2022, Secretary of Health and Human Services Xavier Becerra again renewed the public health emergency declaration that was initiated at the end ...